Year: 2025
Type: article
Study design: Observational Study
Abstract: Background and Aims: Since the start of the Princess Máxima Center in June 2018, we treat all Dutch patients with JMML. Our patients have shown a good outcome as compared to patient cohorts described in the literature and our aim was to present the clinical and molecular characteristics, treatment and outcome of these children.
Source: EJC Paediatric Oncology
Institutions: Princess Máxima Center, University Medical Center Utrecht
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W4415903328
FWCI:
Cites:
Cited by:
Related to: